What Is a Central IRB? Your FAQ Guide

Clinical research is a complex and highly regulated field. Ensuring the safety and ethical treatment of human participants is the foremost priority. Institutional Review Boards (IRBs) are the cornerstone of this protection. As clinical trials have grown in scale, especially across multiple locations, the need for a more efficient review process has led to the rise of the central IRB. This guide answers common questions about what a central IRB is and how it functions. 

What Is an Institutional Review Board (IRB)? 

An Institutional Review Board is an independent committee composed of medical, scientific, and non-scientific members. Its primary responsibility is to review and monitor biomedical and behavioral research involving human subjects. The IRB’s role is to protect the rights and welfare of research participants. They accomplish this by ensuring ethically sound research plans, acceptable risks to participants, and that participants provide voluntary, informed consent. 

What Is a Central IRB? 

A central IRB (cIRB) is an independent Institutional Review Board that delivers ethical review and oversight for multiple research sites within a single clinical trial. Central IRBs sometimes called independent IRB companies, specialize in central IRB services to streamline regulatory review for large, multi-site clinical studies.  

Unlike a local IRB — which is typically affiliated with one institution and can lead to redundant, varying reviews — central IRBs provide unified oversight across many sites, supporting greater consistency and efficiency. This means all participating research locations rely on the same central IRB for review, rather than managing separate local IRB reviews that might result in inconsistent timelines and interpretations.  

Central IRBs operate independently and are equipped to serve a range of sponsors, clinical sites, and contract research organizations nationwide. For sponsors, a central IRB list can be a valuable starting point to identify trusted companies and select the best fit for their study needs. Choosing a central IRB over a local IRB is particularly advantageous for multi-site studies, as it accelerates study startup, standardizes the review process, and ensures ethical standards are uniformly applied — outcomes that are critical for the success of large-scale clinical research.  

Central IRBs are not affiliated with any single institution conducting the research. They are private, commercial entities that specialize in providing comprehensive IRB services to sponsors, contract research organizations (CROs), and research institutions. 

How Does a Central IRB Work? 

A central IRB streamlines the ethical review process for multi-site studies by consolidating oversight under one committee. The process typically follows these steps: 

1. Initial Submission: The study sponsor or CRO submits the research protocol, informed consent forms, investigator brochures, and other relevant documents to the central IRB for a comprehensive review. 

2. Full Committee Review: The cIRB committee convenes to review the submission. They assess the study’s scientific merit, risk-benefit ratio, participant recruitment methods, and the clarity of the informed consent process. Their goal is to ensure the study meets all ethical and regulatory requirements for protecting human subjects.  

3. Approval and Site Onboarding: Once the central IRB approves the study, individual research sites can be brought under its oversight. Each site submits site-specific information, such as investigator qualifications and local recruitment materials, for review. 

4. Ongoing Oversight: The central IRB continues to monitor the study throughout its duration. This includes reviewing protocol amendments, unanticipated problems, and annual continuing review reports from all participating sites. This ensures that participant protections remain in place as the study progresses. 

What Are the Benefits of Using a Central IRB? 

Utilizing a central IRB for multi-site clinical research offers several distinct advantages that enhance study quality and efficiency. 

• Increased Efficiency: By eliminating the need for separate reviews at each local institution, a central IRB significantly reduces administrative burdens and accelerates study startup timelines. All sites operate under a single set of decisions, avoiding duplicate efforts. 

• Greater Consistency: A cIRB ensures that the ethical review is applied uniformly across all participating sites. This consistency is vital for maintaining the integrity of the research protocol and ensuring all participants are protected by the same high standards, regardless of location. 

• Specialized Expertise: Central IRBs often possess deep expertise in specific therapeutic areas and complex study designs. Their review committees have extensive experience with the unique challenges of multi-site studies, leading to more thorough and insightful reviews. 

• Simplified Communication: Sponsors and CROs have a single point of contact for all IRB-related matters. This streamlines communication, making it easier to manage submissions, address queries, and disseminate information to all sites simultaneously. 

Central IRB vs. sIRB: What’s the Difference? 

The terms “central IRB” (cIRB) and “single IRB” (sIRB) are often used interchangeably, which can cause confusion. While they are closely related, there is a subtle distinction based on context and regulation. 

• Central IRB (cIRB): This term typically refers to an independent, commercial IRB that provides review services for multi-site studies. It operates as a centralized ethical review body chosen by a sponsor to oversee their trial. 

• Single IRB (sIRB): This term comes from regulatory mandates, such as the National Institutes of Health (NIH) sIRB policy and the revised Common Rule in the United States. These policies require that most federally-funded, multi-site studies use a single IRB for ethical review. The designated sIRB could be a central IRB, or it could be a local IRB from one of the participating institutions that agrees to serve as the IRB of record for all other sites. 

In essence, a central IRB is a type of IRB that can function as the sIRB for a study. The concept is the same: one IRB provides oversight for all sites. The term “sIRB” emphasizes the regulatory requirement for a single review, while “central IRB” describes the operational model of an independent board providing this service. 

Why Is a Central IRB Important for Modern Clinical Research? 

The landscape of clinical research is evolving. Trials are becoming more global, complex, and data-driven. A central IRB model is uniquely suited to support this evolution. By centralizing the review process, sponsors and CROs can launch studies faster, manage them more effectively, and ensure consistent ethical standards are upheld across dozens or even hundreds of research sites. This efficiency is critical in the effort to bring new treatments and therapies to patients more quickly without compromising safety or ethical integrity. 

For sponsors and institutions planning complex, multi-site clinical trials, partnering with an experienced central IRB is a strategic decision. It provides the robust framework needed to navigate regulatory requirements, protect participants, and achieve research objectives efficiently and reliably. Get in touch with an IRB expert by filling in your information below.